AngioDynamics
ANGO
140 hedge funds and large institutions have $197M invested in AngioDynamics in 2024 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 45 increasing their positions, 58 reducing their positions, and 17 closing their positions.
35% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 17
4% more funds holding
Funds holding: 135 → 140 (+5)
4% less capital invested
Capital invested by funds: $205M → $197M (-$7.94M)
6.18% less ownership
Funds ownership: 87.4% → 81.21% (-6.2%)
22% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 58
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECM
ExodusPoint Capital Management
New York
|
+$5.11M |
| 2 |
KLC
Kent Lake Capital
Reno,
Nevada
|
+$4.63M |
| 3 |
Millennium Management
New York
|
+$3.27M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
+$3.21M |
| 5 |
RA
Royce & Associates
New York
|
+$2.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$4.88M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$4.28M |
| 3 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
-$3.71M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$3.49M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$2.56M |
ANGO Hedge Fund Activity: Q2 2024 in Review
140 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q2 2024, worth a combined $197M — down 3.9% from $205M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new ANGO positions and 17 closed out — a net gain of 6 holders — while 45 added to existing stakes and 58 trimmed.
The largest buyer was ExodusPoint Capital Management, adding an estimated $5.11M. The largest seller was Morgan Stanley, cutting an estimated $4.88M.
- 140 institutional investors held AngioDynamics (ANGO) as of Q2 2024, up from 135 in Q1 2024.
- Funds reported $197M of AngioDynamics stock for Q2 2024, down 3.9% quarter-over-quarter.
- 23 funds opened new AngioDynamics positions in Q2 2024 and 17 closed out, a net change of +6 holders.
- The largest AngioDynamics buyer in Q2 2024 was ExodusPoint Capital Management, an estimated $5.11M added.
- The largest AngioDynamics seller in Q2 2024 was Morgan Stanley, an estimated $4.88M sold.
Based on aggregated 13F filings for Q2 2024.